USPTO Eases Access To Patents Affected By FDA Delays
The U.S. Patent and Trademark Office on Friday announced a new way to gain access to information about patent lifespans affected by the drug approval process, as part of a broader...To view the full article, register now.
Already a subscriber? Click here to view full article